Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Hisamitsu Pharmaceutical Co ( (JP:4530) ) has provided an update.
Hisamitsu Pharmaceutical Co., Inc. has announced the cancellation of 10 million treasury shares, representing 13.70% of the total shares issued before cancellation. This move aims to improve capital efficiency, return profits to shareholders, and allow for a more flexible capital policy in response to changing business conditions.
More about Hisamitsu Pharmaceutical Co
Hisamitsu Pharmaceutical Co., Inc. is a company headquartered in Tosu City, Saga Prefecture, Japan. It operates in the pharmaceutical industry, focusing on the development and distribution of healthcare products.
Average Trading Volume: 173,336
Technical Sentiment Signal: Buy
Current Market Cap: Yen332.3B
Learn more about 4530 stock on TipRanks’ Stock Analysis page.